Competing risks analysis of patients with osteosarcoma: A comparison of four different approaches

Statistics in Medicine

Volumn 20, Issue 5, 2001, Pages 661-684

  Tai, Bee Choo ^a   Machin, David ^a,b   White, Ian ^c   Gebski, Val ^d  

^a National Medical Research Council   (Singapore)

^b UNIVERSITY OF SHEFFIELD   (United Kingdom)

^c LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^d UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BLEOMYCIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; METHOTREXATE;

ADOLESCENT; ADULT; ARTICLE; CANCER; CANCER CHEMOTHERAPY; CANCER SURGERY; CAUSE OF DEATH; CHRONIC DISEASE; CLINICAL RESEARCH; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DATA ANALYSIS; DRUG MEGADOSE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; MULTICENTER STUDY; NONBIOLOGICAL MODEL; OSTEOSARCOMA; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; RISK; STATISTICAL ANALYSIS; TIME; TREATMENT FAILURE;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BLEOMYCIN; BONE NEOPLASMS; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DISEASE-FREE SURVIVAL; DOXORUBICIN; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; METHOTREXATE; NEOPLASM RECURRENCE, LOCAL; OSTEOSARCOMA; PROPORTIONAL HAZARDS MODELS; RISK ASSESSMENT;

EID: 0035869681     PISSN: 02776715     EISSN: None     Source Type: Journal    
DOI: 10.1002/sim.711     Document Type: Article

References (30)

1. Non-parametric estimation from incomplete observations
2. Design and analysis of randomised clinical trials requiring prolonged observation of each patient
3. Competing risks determining event-free survival in early breast cancer
4. Analysis of the probability and risk of cause-specific failure
5. Applying Cox regression to competing risks
6. Regression models and life tables (with discussion)
7. Randomised trial of two regimens of chemotherapy in operable osteosarcoma: A study of the European Osteosarcoma Intergroup
8. Concorde: MRC/ANRS randomised double-blind controlled trial of immediate and deferred zidovudine in symptom-free HIV infection
9. Improved methodology for analyzing local and distant recurrence
10. On the use of cause-specific failure and conditional failure probabilities: Examples from clinical oncology data
11. Marginal or conditional probability curves in summarizing competing risks failure time data?
12. Theory and applications of hazard plotting for censored failure data
13. Non-parametric estimation of partial transition probabilities in multiple decrement models
14. Verifying assumptions of the proportional hazards model
15. A proportional hazards model for the subdistribution of a competing risk
16. Regression analysis of multivariate incomplete failure time data by modeling marginal distributions
17. The robust inference for the Cox proportional hazards model
18. Parametric likelihoods for multiple non-fatal competing risks and deaths
19. Antileukemic effect of chronic graft-versus-host-disease. Contribution to improved survival after allogenic marrow transplantation
20. Multivariate generalisations of the proportional hazards model
21. Cox regression analysis of multivariate failure time data: The marginal approach
22. K-sample tests for cumulative incidence functions and cumulative conditional probabilities: Applied to control of old sites in an advanced breast cancer trial ANZ8613
23. A class of k-sample tests for comparing the cumulative incidence of a competing risk
24. Non-parametric inference for cumulative incidence functions in competing risks studies